# A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic Arthritis

> **NCT00963313** · — · COMPLETED · sponsor: **Dr. FRANCISCO J. BLANCO-GARCIA** · enrollment: 29 (actual)

## Conditions studied

- Psoriatic Arthritis

## Interventions

- **DRUG:** Adalimumab (HUMIRA®)

## Key facts

- **NCT ID:** NCT00963313
- **Lead sponsor:** Dr. FRANCISCO J. BLANCO-GARCIA
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2012-06
- **Final completion:** 2014-06
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2014-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00963313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00963313, "A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic Arthritis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00963313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*